IPP Bureau
.jpg "Telangana commences drone delivery of vaccines from Sept 9")
Telangana commences drone delivery of vaccines from Sept 9
By IPP Bureau - September 09, 2021
The much-awaited drone delivery trials for the delivery of medicines and vaccines will be held in Vikarabad, Hyderabad from 9th September till 17th October.
Novavax initiates Phase 1/2 trials combining vaccine for Covid-19 and seasonal influenza
By IPP Bureau - September 09, 2021
First participants enrolled in Phase 1 clinical trial of combination NanoFlu/NVX-CoV2373 vaccine with Matrix-M adjuvant. The Phase 1/2 study will also evaluate immunogenicity and safety
Evexia Lifecare on expansion mode
By IPP Bureau - September 09, 2021
The company plans to enter the formulation business in January 2022. It has also opened a branch in Hyderabad to trade pharmaceutical chemicals
Eirion Therapeutics mandates HTL Biotechnology to be its exclusive Botulinum API manufacturer.
By IPP Bureau - September 09, 2021
HTL will build, validate and operate a botulinum manufacturing facility in the US
DCGI grants EUA to Truenat for conducting Nipah virus tests
By IPP Bureau - September 09, 2021
Nipah virus (NiV) is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from asymptomatic to acute respiratory infection and fatal encephalitis
New law to regulate drugs and medical devices soon
By IPP Bureau - September 09, 2021
The panel is headed by DCGI Dr VG Somani with representatives from various state drug regulators and health ministry
Equipment shortage and overpriced APIs pinch the pharma industry
By IPP Bureau - September 09, 2021
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
Zydus Cadila gets US FDA approval for antidepressant tablets
By IPP Bureau - September 09, 2021
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
Merck’s KEYTRUDA receives China approval for Esophageal cancer
By IPP Bureau - September 09, 2021
The medicine is now approved for eight indications across five different types of cancer in China.
Sandoz enters agreement for oncology biosimilar medicine bevacizumab
By IPP Bureau - September 09, 2021
Sandoz is committed to building on its leading generic and biosimilar oncology portfolio to further expand patient access while contributing to the sustainability of healthcare systems
WHO to conduct virtual cGMP for vaccine manufacturing
By IPP Bureau - September 08, 2021
The World Health Organisation (WHO), has felt the need to conduct this training to build local capacities in poor countries to bridge the gap and enhance local production
RenovoRx receives New 510(k) clearance from US FDA
By IPP Bureau - September 08, 2021
The company’s RenovoCath Delivery System designed for targeted treatment of solid tumours
Giuliano Perfetti is the new CEO of Jubilant Biosys
By IPP Bureau - September 08, 2021
In his previous assignment Perfetti was associated with Fabbrica Italiana Sintetici (F.I.S) as Chief Commercial Officer
TCS leads in Life Sciences operations services: Everest group
By IPP Bureau - September 08, 2021
TCS provides clinical research services such as clinical data management, regulatory affairs, pharmacovigilance, risk-based monitoring, biostatistics and programming, medical writing, medical affairs and medico marketing, and health economics and outcomes research
Biocon settles suit with Celgene for generic Revlimid
By IPP Bureau - September 08, 2021
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
